Radiologist expertise and responsibilities for off-label use of Urografin before the change in indication by medical health insurance

Jpn J Radiol. 2023 Aug;41(8):909-910. doi: 10.1007/s11604-023-01404-3. Epub 2023 Mar 13.

Authors

Eriko Okuyama¹, Masazumi Matsuda¹, Yu Mori², Naoko Mori³

Affiliations

¹ Department of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
² Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-Ku, Sendai, 980-8575, Japan.
³ Department of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan. naokomori7127@gmail.com.

PMID: 36913009
DOI: 10.1007/s11604-023-01404-3

No abstract available

Publication types

Letter

MeSH terms

Diatrizoate Meglumine*
Humans
Insurance, Health
Off-Label Use*
Radiologists

Substances

Diatrizoate Meglumine